AstraZeneca PLC Files Form 6-K

TL;DR

AZN filed a 6-K, standard foreign issuer report. Nothing new, just housekeeping.

AI Summary

AstraZeneca PLC filed a Form 6-K on August 26, 2025, reporting its status as a foreign issuer. The filing confirms AstraZeneca PLC's principal executive offices are located at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom, and that it files annual reports under Form 20-F.

Why It Matters

This filing is a routine disclosure for foreign issuers, providing updated contact and reporting information to the SEC, which is important for investors tracking the company's regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a foreign issuer and does not contain new material financial or operational information.

Key Players & Entities

• AstraZeneca PLC (company) — Filer of the Form 6-K
• 001-11960 (company) — SEC File Number for AstraZeneca PLC
• 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom (company) — Principal executive offices address
• Form 20-F (company) — Annual report form filed by the registrant
• August 2025 (date) — Reporting period for the Form 6-K
• 20250826 (date) — Filing date

FAQ

From the Filing

0001654954-25-010040.txt : 20250826 0001654954-25-010040.hdr.sgml : 20250826 20250826132213 ACCESSION NUMBER: 0001654954-25-010040 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250826 FILED AS OF DATE: 20250826 DATE AS OF CHANGE: 20250826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11960 FILM NUMBER: 251255476 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE PROVINCE COUNTRY: X0 ZIP: CB2 0AA BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 1 FRANCIS CRICK AVENUE STREET 2: CAMBRIDGE BIOMEDICAL CAMPUS CITY: CAMBRIDGE PROVINCE COUNTRY: X0 ZIP: CB2 0AA FORMER COMPANY: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 6-K 1 a6775w.htm HOLDING(S) IN COMPANY a6775w   FORM 6-K   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Report of Foreign Issuer   Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934   For the month of August 2025   Commission File Number: 001-11960   AstraZeneca PLC   1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA United Kingdom     Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.   Form 20-F X Form 40-F __   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______   Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.   Yes __ No X   If “Yes” is marked, indicate below the file number assigned to the Registrant in connection with Rule 12g3-2(b): 82-_____________     AstraZeneca PLC   INDEX TO EXHIBITS   1. Holding(s) in Company   TR-1: Standard form for notification of major holdings   1. Issuer Details   ISIN   GB0009895292     Issuer Name   ASTRAZENECA PLC     UK or Non-UK Issuer   UK     2. Reason for Notification   An acquisition or disposal of voting rights     3. Details of person subject to the notification obligation   Name   The Capital Group Companies, Inc.     City of registered office (if applicable)   Los Angeles     Country of registered office (if applicable)   USA     4. Details of the shareholder   Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above       City of registered office (if applicable)       Country of registered office (if applicable)       5. Date on which the threshold was crossed or reached   22-Aug-2025     6. Date on which Issuer notified   25-Aug-2025     7. Total positions of person(s) subject to the notification obligation     % of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)   Total of both in % (8.A + 8.B) Total number of voting rights held in issuer Resulting situation on the date on which threshold was crossed or reached   5.009701   0.000000   5.009701   77684561   Position of previous notification (if applicable)